LWA
ABMD

Lenox Wealth Advisors’s Abiomed Inc ABMD Stock Holding History

Lenox Wealth Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-200
Closed -$55K – 695
2020
Q3 		$55K Hold
200
– – 0.01% 159
2020
Q2 		$48K Hold
200
– – 0.01% 169
2020
Q1 		$29K Hold
200
– – 0.01% 208
2019
Q4 		$34K Buy
+200
New +$37.1K 0.01% 236

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Lenox Wealth Advisors's ABMD Position: Q4 2020 in Review

Lenox Wealth Advisors sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 200 shares — an estimated $55K sold.

Lenox Wealth Advisors first reported a position in ABMD in Q4 2019 and held it in 4 quarters. The position peaked at $55K in Q3 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

  • Lenox Wealth Advisors reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
  • Lenox Wealth Advisors sold 200 Abiomed Inc shares in Q4 2020, an estimated $55K.
  • Lenox Wealth Advisors first reported a position in Abiomed Inc in Q4 2019 and held it in 4 quarters.
  • Lenox Wealth Advisors's Abiomed Inc position peaked at $55K in Q3 2020.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Lenox Wealth Advisors's 13F filing for Q4 2020, filed 19 Jan 2021.